“…The crude extract of N025183 (9.8 g), provided by the NCI, was partitioned between EtOAc and water. The EtOAc extract was separated by silica gel column chromatography and preparative TLC techniques to give six known pavine alkaloids, (−)-neocaryachine ( 1 ), (−)-isocaryachine ( 2 ), (−)-crychine ( 3 ), (−)-eschscholtzine- N -oxide ( 4 ), , (−)-norargemonine ( 5 ), , and (−)-bisnorargemonine ( 6 ), , as well as a phenanthroindolizidine alkaloid and (−)-13aα-antofine together with their biosynthetic intermediates, (+)- N -demethylphyllocaryptine, (+)-cinnamolaurine, − (+)- N -methylcoculaurine, and (−)-reticuline. , The structures of all isolated compounds were identified based on various NMR spectroscopic and HRMS data analyses, and their spectroscopic data agreed with published values. We evaluated five ( 1 – 5 ) of the six pavine alkaloids isolated from C. laevigata for antiproliferative activity against five human tumor cell lines, A549 (lung carcinoma), MDA-MB-231 (triple-negative breast cancer), MCF-7 (breast cancer), KB (originally isolated from epidermoid carcinoma of the nasopharynx), and vincristine-resistant KB-subline KB-VIN showing multidrug resistance (MDR) phenotype with overexpression of P-glycoprotein (P-gp) (Table ).…”